WHO Country Office in Jordan

World Health Organization - Regional Office for the Eastern Mediterranean

 
 
The WHO collaborative programme
 
NATIONAL DRUG POLICIES BASED ON ESSENTIAL DRUGS INCLUDING QUALITY CONTROL

Situation analysis
  • The preparation of the national drug policy has been finalized and approved by the Ministries cabinet and a plan of action has been prepared for the implementation of the policy with the help of consultants from the world bank and WHO.
     
  • EDL and Jordan national drug formulary for the EDL was updated during the biennium 2000-2001
     
  • A new drug and pharmacy law and a clinical studies law are in the final process to obtain approval from the cabinet
     
  • Jordan recently established a Jordanian pharmacovigilance system, main centre in drug directorate and two other sites at the Jordan university hospital and Jordan university of science and technology.
     
  • A national policy committee is working as an advisory body to the drug directorate in the evaluation and monitoring of the different activities of the NDP.

Main achievements

  1. Preparation of national drug policy document and approved by MOH and Prime Minister and now process ongoing to print it in English and Arabic
     
  2. Preparation for plan of action for the national drug policy by a technical committee which presents the public and private sector and two experts from World Bank and WHO
     
  3. Preparation of essential drug list and in the present biennium the EDL was updated and divided to different health care levels and it will be printed (10,000) copies and distributed to all concerned parties.
     
  4. Preparation of Jordan National Drug Formulary and in the present biennium JNDF was updated and revised and it will be printed and distributed
     
  5. Developed a national system to promote rational use of drugs by conducting survey about using EDL and conducting training workshop for pharmacists on rational use of drugs and EDL and preparing Guidelines for treatment of Hypertension
     
  6. Preparation of standard Good Laboratory Practice (GP=LP) and standard Good Clinical Practice (GCP).
     
  7. Conduct two training on the standard GLP+GCP

Major Constraint

  • Availability of net work for regular key persons and addresses in different countries
     
  • Training on the use of network information

Objectives

(1) a: improving the quality of drug available on the market by implementing GMP, GLP, TCP standards.
b: training of regulatory people on the standards mentioned above
(2) Availability of essential drugs at reasonable prices
(3) Rational drug use through:
a: implementation of EDL and to the different levels of health care.
b: implementation of standard treatment protocols.
c: use of national drug formulary.

Priorities
 

  • Reviewing the implementation of SIAMED system.
     
  • Training on the SIAMED system use.
     
  • Training on the adverse drug reporting system.
     
  • Developing training strategies on RUD and training packages for health staff and consumers.

Evaluation and monitoring indicators

  • Full and efficient use of SIAMED system.
     
  • Full and efficient use of adverse drug reaction and reporting system.
     
  • Rational use of drugs.
     

DRUG QUALITY CONTROL PROGRAMME

Situation analysis

The drug quality control laboratory is the only reference laboratory in Jordan that controls the analysis of each batch of local manufactured and imported drugs, surgicals and disposables. In addition to this responsibility it also receives recalled drugs from the inspection department in MOH and undertakes all the required tests.

The MOH is responsible for developing and updating the level of performance of drug quality control laboratory by providing it with updated supplies and equipment and by providing training courses in different aspects for technicians to keep them well trained and experienced.

Main achievements

During the biennium 200/2001, the programme has achieved the following:

  • Provision of S&E needed for laboratory analysis (under process)
     
  • Award of two fellowships on drug quality control (under process).
     
  • Conducted a national workshop on GLP guidelines for laboratory and drug directorate staff.
     
  • Developed GLP guidelines document.
     
  • Developed a document on guidelines for quality control of natural products.

Main constraints

  • Lack of adequate logistics support
     
  • Lack of short term training courses for technicians.
     

Objectives

  • To strengthen the national quality assurance system and to include quality control for biological products, vaccines, and hormones.

Priorities

  • Training on Drug Quality Control.
     
  • Performance indicators:
     
  • Number of professionals trained.